Dr. (MS) S. Ganguly

Important Links

Contact Us

Email - swastikaganguly@bitmesra.ac.in
Phone - 8809966752

Resume

RESUME

 

 

  1. Name and address for correspondence:

DR.SWASTIKA GANGULY,M. PHARM., Ph.D

PROFESSOR, DEPARTMENT OF PHARMACEUTICAL SCIENCES AND TECHNOLOGY,

BIRLA INSTITUTE OF TECHNOLOGY, MESRA,

RANCHI-835215,JHARKHAND,INDIA

 

  1. Designation : PROFESSOR

 

  1. Email Id :swastikaganguly@bitmesra.ac.in       

 

  1.  Mobile:8809966752 

 

  1. Date of Birth :20.12.1969

 

  1. Gender (M/F/T):F

 

  1. Category (Gen/SC/ST/OBC):GEN

 

  1. Specialization (Area of interest, up to 5):Drug Design and discovery, development and synthesis of NCEs, AntiHIV drug discovery and development

9.

Academic Qualification (Undergraduate Onwards)

 

S.No.

Degree

Year

Branch/Discipline

University/Institution

% Marks or Grade

1.

B. Pharm

1992

Pharmaceutical Sciences

Birla Institute of Technology, Mesra

84.80%

2.

M.Pharm

1994

Pharmaceutical Chemistry

Birla Institute of Technology, Mesra

77.045              77.04%

3.

Ph.D.

2001

Pharmaceutical Chemistry

Birla Institute of Technology, Mesra

NA

 

10. Ph.D thesis title: Synthesis and Study of Newer Imidazole analogs

     Specialization: Medicinal Chemistry

     Supervisor: Dr. B. K. Razdan

     University: Department of Pharm. Scs. And Tech, Birla Institute of Technology, Mesra, Ranchi

     Year: 2001

 

 

 

 

 

 

 

 

 

 

 

 

 

11. Work experience (in chronological order – Last 5):

 

Sl. No.

Designation

Name of the

From

To

Responsibility

 

 

Institute/Organization

Month-year

Month-Year

 

 

 

 

 

 

 

1.

Vice Principal

Ranchi College of Pharmacy, Ranchi

01.08.1999

09.06.2000

Teaching UG students as well as administrative responsibilities

2.

Lecturer

Kanak Manjari Institute of Pharmaceutical Sciences, Chhend, Rourkela-15, Orissa

(Degree & Diploma course)

23.08.2000

26.03.2001

Teaching UG students as well as administrative responsibilities

3.

Assistant Professor

Birla Institute of Technology, Mesra, Ranchi

 

28.03.2001

30.09.2005

Teaching UG and PG students as well as administrative responsibilities

      4

Senior Lecturer

Birla Institute of Technology, Mesra, Ranchi

 

01.10. 2005

31.05.2007

Teaching UG , PG and guiding Ph.D.students as well as administrative responsibilities

     5

Reader

Birla Institute of Technology, Mesra, Ranchi

 

01.06.2007

31.05.2009

Teaching UG , PG and guiding Ph.D.students as well as administrative responsibilities

     6

Associate Professor

Birla Institute of Technology, Mesra, Ranchi

 

01.06.2010

31.06.2015

Teaching UG , PG and guiding Ph.D.students as well as administrative responsibilities

     7

Professor

Birla Institute of Technology, Mesra, Ranchi

 

01.07.2015

Till date and continuing

Teaching UG , PG and guiding Ph.D.students as well as administrative responsibilities

 

 

12. Professional Recognition/ Award/ Prize/ Certificate/Fellowship received by the PI. (top 10):

 

S.No.

Name of Award/ Certificate

Awarding agency

Year

        1.

AL AMEEN COLLEGE OF PHARMACY AWARD

Indian Journal of Pharmaceutical Education

2005

        2.

THE BEST PAPER AWARD for the oral presentation entitled “Molecular Modelling of Azole antifungal agents active against Candida Albicans :A ComFA and ComSIA study”

Nanotechnology Research Centre, Kalyan

2006

3.

Chartered Chemist of the Institution of Chemists

Institution of Chemists

 

4.

APTI(EZ) Coordinator of Women’s Forum

APTI

2016

 

       13. Publications:

 

 

 

 

 Naresh Panigrahi, Swastika Ganguly, Jagadeesh Panda,  Ultrasound Assisted Synthesis, Characterization and Antimicrobial Evaluation of Novel Oxazolidinone- Biphenyl Chalcone Hybrid Derivatives, Indian Journal of Pharmaceutical Education and Research ,53 ,Issue 2 ,Apr-Jun, 201922-39. .(SCI)

 

B. Pramodh ,  N.K. Lokanath ,  S. Naveen ,  P. Naresh , S. Ganguly , J. Panda Molecular structure, Hirshfeld surface analysis, theoretical investigations and nonlinear optical properties of a novel crystalline chalcone derivative: (E)-1-(5-bromothiophen-2-yl)-3-(p-tolyl)prop-2-en-1-one, Journal of Molecular Structure 1161 (2018) 9- 17.(SCI)

 

 

Naresh Panigrahi , Swastika Ganguly , Jagadeesh Panda, Synthesis, Antimicrobial Evaluation and Molecular Docking Studies of Novel Oxazolidinone-Thiophene Chalcone Hybrid Derivatives, : Research Journal of Pharmacy and Technology, 11,(12), 2018, 5611-5622

1

Biplab Debnath,, Ping Wang,, Liu-Meng Yang,, Yong-Tang Zheng,, Swastika Ganguly, Synthesis And Biological Evaluation Of Novel (2-Oxo-3-(Arylimino)Indolin-1-Yl)-N-Aryl Propanamides As Anti-Human Immunodeficiency Agents, 11( 12), 2018,1-7.

 

2

Rohit Singh  and Swastika Ganguly, " Design, Synthesis and Evaluation of some novel1-phenyl-3-(5-phenyl-1H-imidazol-1-yl)thiourea derivatives as antiHIV agents "Indianl Journal of Pharmaceutical Education and Research, Oct-Dec 2018; Vol. 52(4): 655-65.

 

3

Rohit Singh  and Swastika Ganguly, Synthesis ,Antimicrobial Evaluation and structure activity relationship (SAR)studies of some 1-phenyl-3-(5-phenyl-1H-imidazol-1-yl)thiourea derivatives .Antiinfective Agents.  2017; 15, 1.

 

4

Rohit Singh  and Swastika Ganguly, " MOLECULAR DOCKING STUDIES OF NOVEL IMIDAZOLE ANALOGS AS HIV-1-RT INHIBITORS "International Journal of Pharmaceutical Sciences and Research, 2017; Vol. 8(9): 1000-07.

 

5

Rohit Singh  and Swastika Ganguly, " Synthesis and antimicrobial evaluation of some 1-phenyl-3-(5-phenyl-1H-imidazol-1-yl)thiourea derivatives "Indian Journal of Heterocyclic Chemistry, Apr-Jun 2018; Vol. 28(3): 361-366.

 

6

Radhe S. Bahare, Swastika Ganguly, Ritesh Agrawal and Subodh N. Dikshit,Thiazolidine: A Potent Candidate for Central Nervous System Diseases, Central Nervous System Agents in Medicinal Chemistry, 2016, 16, DOI : 10.2174/1871524916666160107110754

7

 

 K. Sony Jacob, Swastika Ganguly, Synthesis, anti microbial screening and cytotoxic studies of some novel pyrazole analogs, Journal of Applied Pharmaceutical Sciences,  2016, 6 (11), 135-141.

8

Sony Jacob K.* and Swastika Ganguly, A battle against aids: new pyrazole key to an older lock-Reverse Transcriptase,International Journal of Pharmacy and Pharmaceutical Sciences,2016,8(11),75-79.IF=0.51

9

 

 Sony Jacob K.* and Swastika Ganguly, Facile Synthesis, Antimicrobial Studies and Structure - Activity Relation-ship Studies of Some Novel Pyrazole Analogs,Anti-infective Agents,2017,15 (accepted)

10

Sony Jacob K, Swastika Ganguly, Pravin Kumar, Raju Poddar & Anoop Kumar, Homology model, molecular dynamics simulation and novel pyrazole analogs design of Candida albicans CYP450 lanosterol 14 α-demethylase, a target enzyme for antifungal therapy, Journal of Biomolecular Structure and Dynamics,2017,  35, (7), 1446–1463 IF=1.060

11

Sonali Biswas, Sunita Keshri, Sudipta Goswami, Jinu Isaac, Swastika Ganguly & Nikolai Perov (2016): Antibiotic loading and release studies of LSMO nanoparticles embedded in an acrylic polymer, Phase Transitions, DOI: 10.1080/01411594.2016.1156681

 

12

Swastika Ganguly, Sony Jacob K, Therapeutic outlook of pyrazole analogs: A mini review, Mini Reviews in Medicinal Chemistry, DOI: 10.2174/1389557516666151120115302 IF=2.903

13

Jinu Isaac, Swastika Ganguly, Animesh Ghosh, Comilling of telmisartan with poly (vinyl alcohol) – an alkalanizer free green  approach to ensure its bioavailability, European Journal of Pharmaceutics and Biopharmaceutics 101 (2016) 43–52. IF=4.245

14

Biplab Debnath & Swastika Ganguly ,Synthesis and Evaluation of Novel 2-oxo-3-

(arylimino) Indolin-1-yl)-N-aryl acetamide Analogs as Promising Anthelmintic Agents, International Journal of Pharmaceutical Research,Oct-Dec 2015, 7(4), 52-61.

15

Biplab Debnath & Swastika Ganguly , Biological Evaluation, in Silico Docking and Virtual ADME Studies of novel   2-(2-oxo--3-(arylimino) Indolin-1-yl)-N-aryl acetamides as Potent Anti-breast Cancer Agents,Monatshefte fur Chemie - Chemical Monthly(accepted) DOI 10.1007/s00706-015-1566-9 IF=1.04

16

Biplab Debnath & Swastika Ganguly, Synthesis, characterization, and anthelmintic activity of isatin analogs against pheritima posthuma, Asian J Pharm Clin Res, Vol 8, Issue 5, 2015, 1-6

17

Biplab Debnath & Swastika Ganguly Synthesis, Biological Evaluation, in Silico Docking and Virtual ADME Studies of Novel Isatin Analogs as Promising Antimicrobial Agents, Antiinfective agents 2015, 13,1-15.

18

Biplab Debnath & Swastika Ganguly (2015): Synthesis of Some Novel (2-Oxo-3-(arylimino) indolin-1-yl)-Naryl acetamides and evaluation as Antimicrobial Agents, Toxicological & Environmental Chemistry, DOI: 10.1080/02772248.2015.1061524 IF=0.795

 

      

 

19

Swastika Ganguly, Surbhi Mishra, Ira Sankrityayan and Abhimanyu Dev,“Synthesis, antimicrobial activities and binding mode analysis of some novel N-substituted imidazoles and nitroimidazoles”Indian Journal of Heterocyclic Chemistry, 24,Jan-March 2015, pp373-380.IF=.I63

 

20

Geeta Yadav and Swastika Ganguly, Synthesis, antiHIV , antimicrobial evaluation and structure activity relationship studies of some novel benzimidazole derivatives , Antiinfective agents, 13,2015, 65-77.

21

Geeta Yadav and Swastika Ganguly, Structure activity relationship (SAR) study of benzimidazole scaffold for different biological activities: a mini-review , Eur. J. Med. Chem, 97 (2015), 419- 443. DOI 10.1016/j.ejmech.2014.11.053,IF=4.519

22

  1. Geeta Yadav , Swastika Ganguly, S. Murugesan and A. Dev,  Anti-HIV and Antimicrobial Activity in vitro of some New benzimidazole derivatives, International Journal of Research in Pharmaceutical Sciences 5(4),2014.243-249.

 

23

  1. Radhe Shyam Bahare, Swastika Ganguly, Kiattawee Choowongkomon and Supaporn Seetaha, Synthesis, HIV-1 RT inhibitory, antibacterial, antifungal and binding mode studies of some novel N-substituted 5-benzylidine-2,4-thiazolidinediones,Daru Journal of Pharmaceutical Sciences, DOI 10.1186/s40199-014-0086-1.IF=1.653

 

24

  1. Biplab Debnath and Swastika Ganguly, Molecular docking studies and ADME prediction of novel isatin analogs as HIV-1-RT inhibitors with broad spectrum chemo therapeutic properties, Asian Journal of Pharmaceutical and Cinical Research, 2014,  7(5 ), 186-194 .

 

25

  1. Swastika Ganguly and Biplab Debnath, Molecular Docking Studies and ADME Prediction of Novel Isatin Analogs with Potent Anti-EGFR Activity, Medicinal Chemistry, 2014, 4(8), 558-568.

 

26

Penta Ashok, Swastika Ganguly and Sankaranarayanan Murugesan, Manzamine alkaloids: isolation, cytotoxicity, antimalarial activity and SAR studies, Drug Discovery Today, 2014,19(11) , 1781-1791.IF=6.369

27

  1. Pravinkumar Sable, Swastika Ganguly, Synthesis of Some Thienopyrimidine Derivatives as Antimicrobial Agents, Ind. Jr. Het. Chem, 2014, 23, 245-246.

 

28

  1. Swastika Ganguly, Nalini Singh and Arpita Upadhyay, Synthesis, antibacterial activities and binding mode analysis of some novel 1,4 diaryl imidazole thiones , Ind. Jr. Het. Chem., April-June 2014, 23, ,419-423.

 

29

  1. Pravinkumar N. Sable, Swastika Ganguly and  Pravin D. Chaudhari, An efficient one-pot three-component synthesis and antimicrobial evaluation of tetra substituted thiophene derivatives, Chinese Chemical Letters, 2014, (25), 1099–1103.

 

30

  1. Jagdish Sahu, Swastika Ganguly and Atul Kaushik, Synthesis and antimicrobial activity of some novel fused heterocyclic 1,2,4-triazolo [3,4-b][1,3,4] thiadiazine derivatives, Journal of Advanced Pharmaceutical Technology & Research, Apr-Jun 2014 , 5 (2) ,90-95.

 

31

Naresh Panigrahi, Swastika Ganguly, Jagadeesh Panda, Y. Praharsha, Ultrasound Assisted Synthesis and Antimicrobial Evaluation of Novel Thiophene Chalcone Derivatives, Chemical Science Transactions, 2014, 3(3), 1163-1171 .

 

32

Jagdish K. Sahu ,  Swastika Ganguly , Atul Kaushik, Synthesis of Some Novel Fused Heterocyclic 1,2,4-triazolo [3,4-b][1,3,4] Thiadiazole Derivatives as Possible Antimicrobial Agents, Journal of Applied Pharmaceutical Science,  February, 2014,  4 (02), 081-086,

 

33

AshokPenta, Subhash Chander,  S.Ganguly,  S.Murugesan,  De novo design and in-silico studies of novel 1-phenyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic acid derivatives as HIV-1 reverse transcriptase inhibitors, Med.Chem.Res,. DOI 10.1007/s00044-014-0945-9.

 

34

Radhe Shyam Bahare and Swastika Ganguly, Effect of Electronegative Groups on the Antimicrobial activity of 3,5 disubstituted thiazolidine 2,4-diones, Antiinfective agents, 2014, 12, 112-119.

 

35

Subhashish Banerjee, Swastika Ganguly, Kalyan Kumar Sen, Kiattawee Choowongkomon, Supaporn Seetaha, Synthesis, evaluation and binding mode analysis of some novel triazole derivatives as antimicrobials, Journal of Advanced Pharmaceutical Education and Research 2013, 3 ,494-511.

 

36

Swastika Ganguly, Patel Hardik Sureshchandra and Abhimanyu Dev,Synthesis , antibacterial and antifungal activities of some novel 1-(4,5-dihydro-3,5-diaryl-1H-pyraol-4-yl)-1H-imidazoles, Indian Journal of Heterocyclic Chemistry, Jan-March 2013, 22, 301-304.

 

37

Sankaranarayanan Murugesan, Ashok Penta, Kakamanu Kishore Babu,  Swastika Ganguly, Lack of human immunodeficiency virus-1 integrase inhibitory activity of novel 3a, 4, 7, 7a-tetrahydro-1H-isoindole-1, 3(2H)-dione derivatives, Journal of Pharmaceutical Negative Results, 2013, 4(1), 13-18.

 

38

Ashok Penta, S. Ganguly and S. Murugesan, Design and synthesis of 3a,4,7,7a-tetrahydro-1H-isoindole-1,3(2H)-diones as inhibitors of HIV-1 reverse transcriptase, International Journal of Pharmacy & Pharmaceutical Sciences 2013,  5(3), 659-664.

 

39

Ashok Penta, S. Ganguly and S. Murugesan, Design, synthesis and evaluation of 2-(1,3-dioxoisoindolin-2-yl)-N-phenylacetamides as Inhibitors of Reverse Transcriptase,Der Pharmacia Chimica 2013, 5(4), 10-19.

 

40

P.A. Shok, S. Ganguly and S. Murugesan, Review on in-vitro anti-malarial activity of natural -carboline alkaloids, Mini Reviews in Medicinal Chemistry, 13, 2013,  DOI :10.2174/1389557511313120008  

 

41

Ashok Penta , Swastika Ganguly and Murugesan Sankaran , Design and synthesis of tetrahydrophthalimide derivatives as inhibitors of HIV-1 Reverse Transcriptase, Organic Medicinal Chemistry Letters, 2013, 3:8,1-8.

 

42

Subhashish banerjee, Swastika Ganguly and Kalyan Kumar Sen, A Review on 1,2,4-Triazoles, Journal of Advanced Pharmaceutical Education and Research ,July-Sept 2013 , 3, 101-115.

 

43

Jagdish K. Sahu,  Swastika Ganguly, Atul Kaushik, Triazoles: A Valuable Insight into the Recent Development and Biological Activities, Chinese Journal of Natural Medicines, 2013, 11(5),456-465

44

Krishnan Suresh Kumar, Swastika Ganguly, K. Vijayapandi and      , “Synthesis, antiviral and cytotoxic investigations of 2-(4-chlorophenyl)-3-substituted quinazolin-4(3H) ones” International Journal of Drug Design, January–March 2012, 3(1),702-712.

 

45

Rahul Mystry and Swastika Ganguly, “Imidazole as an antiepileptic”, Medicinal Chemistry Research, DOI 10.1007/s00044-009-9191-y

 

46

Rahul Mishra, Swastika Ganguly, Kalyan Kumar Sethi and Papiya Mitra Mazumder, “Synthesis and Anticonvulsant Activity of Some Novel 2-Methyl Imidazole Derivatives” , Letters in Drug Design and Discovery, 2012, 9,402-408.

 

47

Swastika Ganguly, B.S. Nagraj and D. Sriram, Synthesis, antimycobacterial activities and docking studies of some novel diarylimidazoles targeted at mycobacterium tuberculosis p-450DM, Indian Journal of Heterocyclic Chemistry, April-June 2012, 21, 321-330.

 

48

Nagaraj Selvaraj, Swastika Ganguly, Comparative Molecular Similarity Indices Analysis of Some 1-Substituted Imidazole Analogues as Candida Albicans P450 – Demethylase Inhibitors , Med. Chem. Res. DOI 10.1007/s00044-012-0251-3P.

 

49

Ashok, Kakumanu Kishore Babu, S. Murugesan and S. Ganguly, Design and Docking Studies of Some Novel 1-Phenyl-2,3,4,9-tetrahydro-1H-pyrido[3,4-b]indole-3-carboxylic acids as Inhibitors of Human Immunodeficiency Virus Type-1 Reverse Transcriptase, Asian Journal of Chemistry; 2012, 24( 12),5857-5860.

 

50

Swastika Ganguly, Radhe Shyam Bahare, Molecular docking studies of some novel thiazolidinedione analogs as HIV-1-RT inhibitors, Med. Chem. Res. DOI 10.1007/s00044-012-0339-9.

 

51

Isaac, Jinu, Kaity, Santanu, Ganguly, Swastika, Ghosh, Animesh , Microwave induced solid dispersion technology to improve bioavailability of Glipizide" , Journal of Pharmacy and Pharmacology, DOI: 10.1111/j.2042-7158.2012.01595.x.

 

52

S Banerjee, S. Ganguly and K. K. Sen, Denovo insilico design of triazole analogs as reverse transcriptase inhibitors, Der Pharmacia Lettre, 2012, 4 (6), 1888-1900

53

S.K. Krishnan, S. Ganguly, R. Veerasamy, B. Jan, “Synthesis, antiviral and cytotoxic Investigation of 2-Phenyl-3-Substituted Quinazolin-4(3h)-ones, European Review for Medical and Pharmacological Sciences”, 15, 2011, 673-682.

 

54

Swastika Ganguly, Vatsal Vijay Vithlani, Anup Kr. Kesharwani, Ritu Kuhu, Baskar L, Papiya Mitramazumder, Ashok Sharon and Abhimanyu Dev, Synthesis , antibacterial   and potential anti-HIV activity of some novel imidazole analogs, Acta Pharm, 2011, 61,187-201

55

Baskar Lakshamanan, Papiya MitraMazumder, D. Sasmal, S. Ganguly and Simon Santosh Jena, In vitro anthelmentic activity of some 1-substituted imidazoles derivatives , Acta parasitologica Globalis, 2011, 2(1), 01-05.

 

56

Baskar L, Papiya Mitramazumder, D. Sasmal, Swastika Ganguly, Synthesis, antispasmodic and antidiarrheal activities of some 1-substituted imidazole derivatives, Acta Pharm, 2011, 61,227-236.

 

57

S. Murugesan and Swastika Ganguly, “3D QSAR - Comparative Molecular Similarity Indices Analysis of 2-Heteroarylquinoline-4-amines as Possible Anti-HIV-1 Agents”, International Journal of Drug Design, April- June 2011, 2(2). 442-451.

 

58

S. Murugesan and Swastika Ganguly, “Synthesis, evaluation and molecular modeling studies of some novel tetrahydroisoquinoline derivatives targeted at the HIV-1 reverse transcriptase”, Der Pharmacia Lettre, 2011, 3 (6), 317-332.

 

59

S.Murugesan, S. Ganguly and G. Maga, “Synthesis, evaluation and molecular modeling studies of some novel 3-(3, 4-dihydroisoquinolin-2(1H)-yl)-N-(substituted-phenyl) propanamides as HIV-1 non-nucleoside Reverse Transcriptase Inhibitors”, Journal of Chemical Sciences, March 2010, 122(2), 169-176.

 

60

Avinash Patil, Swastika Ganguly, Sanjay Surana,Synthesis and antiulcer activity of 2-[5-substituted-1-H-benzo (d) imidazol-2-yl sulfinyl] methyl-3-substituted quinazoline-4-(3H)ones”, Journal of Chemical Sciences May 2010, 122( 3), 443–450.

 

61

L. Baskar, Papiya Mitra Mazumder, D. Sasmal and Swastika Ganguly, “H2-Receptor Antagonistic Activity of some N-Substituted 2-Methyl Imidazoles”Pharmacologyonline, 2009, 3, 56-63.

 

62

L. Baskar, Papiya Mitra Mazumder, D. Sasmal And S.Ganguly, “Antispasmodic Effects Of Some Nsubstituted 2-Methyl Imidazole Derivatives on Guinea Pig Ileum”, International Journal Of Pharm Tech Research,2(1), Jan-Mar 2010,760-764.

 

63

Ponnilavarasan.I, Rajasekaran.A, Sivakumar.K.K, Sundaramoorthi.C, Swastika

Ganguly, Sivasakthi.R, ‘Synthetic Approach for the Novel Semicarbazones  of

Quinazoline ring and its Biological Activity’ Asian Journal of Research in       Chemistry , April-June 2010,  3(2), 1-5.

 

64

Poonilavarasan Ilangovan, Swastika Ganguly, Vijay Pandi and James P. Stables, “Design and Synthesis of Novel Quinazolinone derivatives as broad spectrum anticonvulsants” Der Pharmacia Lettre2010, 2 (1),13-21.

 

65

Swastika Ganguly, Sankaran Murugesan, Naru Prasanthi , Onur Alptürk, Brian Herman  and Nicolas Sluis-Cremer, “Synthesis and Anti-HIV-1 Activity of a Novel Series of Aminoimidazole Analogs”, Letters in Drug Design and Discovery 2010, 7( 5), 318-323.

 

66

Supriyo Saha, Subhasis Banerjee and Swastika Ganguly, “Molecular Docking Studies Of Some Novel Hydroxamic Acid Derivatives”, International Journal of Chem Tech, 2010, .2, (2), 932-936

67

Krishnan Suresh Kumar, Swastika Ganguly, Ravichandran Veerasamyand Erik De Clercq, “ Synthesis, Antiviral activity and Cytotoxicity Evaluation of Schiff bases of some 2-PhenylQuinazoline-4(3)H-ones”,European Journal of Medicinal Chemistry 2010, 45 ,5474-5479.

 

68

Baskar Lakshmanan, Papiya Mitra Mazumder, Dinakar Sasmal and Swastika Ganguly, “Biologically Active Azoles: Synthesis, Characterization     and antimicrobial Activity of Some 1-substituted imidazolesDer Pharmacia Lettre, 2010, 2(4), 82-89.

 

69

Baskar Laxmannan, Papiya Mitramazumder,D. Sasmal and S. Ganguly, “Antiulcer activity of 1-substituted imidazoles against gastric ulcers in rats”,Pharmacologyonline,  2010, 3,503-513.

 

70

Baskar Lakshmanan, Papiya Mitra Mazumder, Dinakar Sasmal and Swastika Ganguly, “Evaluation of antioxidant potential of Some N-1-Substituted Imidazole Derivatives”, Journal of Global Trends in Pharmaceutical Sciences , Oct –Dec 2010, 1(1), 14- 22.

 

71

S. Ganguly, Gopalakrishnan V. and R. Chandra, “Synthesis and antibacterial activity of some new 1- substituted 2- methyl-4- nitroimidazoles” International Journal of Chemical Sciences 2009, 7(1), 204-210.

 

72

M. Ganesh,S. Uppatyay, R. Tivari, K. Kamalakannan,G. Rathinavel, S. Ganguly and T. Sivakumar, “Quantitation of Alfuzosin Hydrochloride in Pharmaceutical Formulations by RP-HPLC”, Pak. Jr. Pharm. Scs, 2009, 22(3), 263-266

 

73

M. Veerapandian, M. Marimuthu, P. Ilangovan, S. Ganguly, Kyu-Sik Yun, Sanghyo Kim, Jeongho An, “Analytical and biological standardization of quinazoline semicarbazones derivatives” Med. Chem. Res. DOI 10.1007/s00044-009-9191-y

 

74

Avinash Patil , Swastika Ganguly , Sanjay Surana , Sanjay Pekamwar ,  and Abhay Sangamwar, Docking Studies Of Novel 2-[5-Substituted-1-H Benzo   (D)Imidazole-2-Yl Sulfinyl] Methyl 3-Substituted Quinazoline-4(3H)Ones, International Journal of Pharm Tech Research, 1(4), 2009,   1227-1233.

 

75

Swastika Ganguly  and Naresh Panigrahi, Docking Studies Of Some Novel 1-{2-(Diarylmethoxy)Ethyl]-2-Methyl-5-Nitroimidazole(DAMNI)Analogs”,International Journal of ChemTech Research ,Oct-Dec 2009, Vol.1, No.4, 974-984.

 

76

Avinash Patil, Swastika Ganguly and Sanjay Surana, “Synthesis and antiulcer activity of novel 2-[5-substituted 1H-benzo(d) imidazole-2-yl sulfinyl) methyl -3-substituted quinazoline-4(3H)ones” Indian Journal of Het. Chem., Oct-Dec 2009, 19, 113-115.

 

77

Swastika Ganguly,S. Murugesan and Giovanni Maga, “Synthesis, Evaluation And Molecular Modeling Studies Of Some Novel Tetrahydroisoquinoilne Derivatives Targeted At The HIV-1 Reverse Transcriptase” Indian Journal of Het. Chem, April 2009, 18(4), 357-360.

 

78

S. Ganguly and V. Gopalakrishnan, 3D QSAR studies of DAMNI analogs as possible non nucleoside Reverse transcriptase Inhibitors, E Journal of Chemistry, 2008, 5(S2), 1103-1113.

 

79

Papiya Mitramazumder, Rana Datta, R.N. Majee and S. Ganguly, Synthesis and antimicrobial activity of some derivatives of aleuritic acid, Indian Journal of Heterocyclic Chemistry, July Sept 2008, 18, 73-76.

 

80

M. Ganesh, B. Thangabalan, Swastika Ganguly, T. Sivakumar, “Simple extractive colorimetric determination of oxaprozin by acid-dye complexation methods  in solid dosage form” E journal of chemistry, July 2008, 5(3), 593-597

81

Mani Ganesh, Mani Vasudevan, Kaliappan Kamalakannan, Arthanari Saravana Kumar1, Mari Vinoba , Swastika Ganguly , Thangavelu Sivakumar, “Anti-inflammatory and Analgesic Effects of Pongamia glabra Leaf Gall Extract” Pharmacologyonline, , 2008, 1,497-512.

 

82

M. Ganesh, B. Thangabalan, Rahul Patil, Dinesh Thakur, A.Saravana Kumar, M. Vinoba, Swastika Ganguly, T. Sivakumar, “Validated HPLC Method for Analysis of Oxaprozin in a Formulation Acta Chromatographica, 2008, 20 (2), 165–173

83

M. Ganesh, B. Thangabalan, Swastika Ganguly, T. Sivakumar, “Simple extractive colorimetric determination of oxaprozin by acid-dye complexation methods  in solid dosage form” E journal of chemistry, July 2008, 5(3),593-597.

 

84

Mani Ganesh, Mani Vasudevan, Kaliappan Kamalakannan, Arthanari Saravana Kumar1, Mari Vinoba , Swastika Ganguly , Thangavelu Sivakumar, “Anti-inflammatory and Analgesic Effects of Pongamia glabra Leaf Gall Extract” Pharmacologyonline, 2008, 1, 497-512.

 

85

S. Ganguly and V. Gopalakrishnan, 3D QSAR studies of DAMNI analogs as possible non nucleoside Reverse transcriptase Inhibitors, E Journal of Chemistry, 2008, 5(S2), 1103-1113.

 

86

Ganguly S. and Razdan B.K., ‘Synthesis of Novel 2-Methylimidazole    Derivatives, Indian Journal of Heterocyclic Chemistry, July-Sept 2007, 17, 87-88.

 

National:

1)

Swastika Ganguly, Shweta Sinha and Abhimanyu Dev, “Synthesis and antimicrobial activity of some new bisimidazole analogs Journal of Institution of Chemists, 2012, 84(4), 124-128

 

2)

S. Ganguly, N. Panigrahi, S.N. Cremer and A. Dev, “Microwave Assisted Synthesis and Evaluation Of Some 1-{2-(hydroxyethyl]-2-Methyl-5-Nitroimidazole Analogs” Journal of Institution of Chemists, 2011, 83,65-71.

 

3)

Baskar L, Papita Mitramazumder, D. Sasmal and Swastika Ganguly, “In-vitro      antihistaminic activity of some 1-substituted imidazoles- H2receptor antagonism”, Journal of Pharmaceutical Sciences and Research, 2011, 3(1), 961-965.

 

4)

Swastika Ganguly, Pankaj kr. Gupta, Abhimanyu Dev, “Synthesis and antimicrobial evaluation of some 1-substituted 2-methyl-5-nitroimidazoles”, Pharmbit, Jan-Jun 2010, XXI(1),29-32.

 

5)

S. Ganguly, K.J. Patel and R. Chandra, “Synthesis and Antimicrobial Evaluation of some 1-[5-(p-SubstitutedPhenyl)-2-Mercapto-1H-Imidazol-1-Yl]-3-(Aryl)Thioureas”, Journal of Institution of Chemists (India), 2010, 82(2), 52-58.

 

6)

Swastika Ganguly and S. Murugesan, “Synthesis and in vitro Antimicrobial Activities of Novel Tetrahydroquinoline and Tetrahydroisoquinoline Analogues”, J.Ind. Chem Soc., 2010, 87,1-7.

 

7)

Poonilavarasan Ilangovan, Swastika Ganguly and Vijay Pandi, “Design and Synthesis of Novel Quinazolinone derivatives as broad spectrum anticonvulsant and antimicrobial agents”, Journal of Pharmacy Research, 2010, 3(4), 703-706.

 

8)

Ganguly S, Mishra R, “Comparative Molecular Similarity Indices Analysis of 1-

 (Naphthylalky1)-1H–imidazole Analogs with Antiepileptic Activity” Journal of Young

 Pharmacists, Oct-Dec, 2010, 2(4), 388-392.

 

9)

S. Ganguly, P. MitraMazumder, D.Sasmal, G.M. Panpalia, S.Jha, S.G.Panpalia and R.Chandra, ‘Spirulina as a green remedy – An Overview’, Science and  Culture, 2009, 75(1-2), 12-17.

 

10)

Avinash Patil, Swastika Ganguly and Sanjay Surana, “Synthesis and Antiulcer Activity of 2-[ 5-substituted 1-H-benzo(d)imidazole-2-yl sulfinyl methyl ]3-Phenyl Quinazoline-4(3H)one Derivatives” Asian Journal of Chemistry, 2009, 1(2), 1491-1494.

 

11)

S. Ganguly, S. P. Bhatnagar and V. Kaushik, “Development of software for identification of indigenous drugs”, Pharmacognosy Research, 2009, 1(1), 35-37.

 

12)

S. Ganguly, Vishwanathan K and R. Chandra, “Synthesis and Antibacterial activity of some N-substituted -3-(2-methyl-5-nitro-imidazol-1-yl)-propionamides”, Journal of Institution of Chemists (India), (2009), 81(2), 57-62.

 

13)

S. Ganguly and N. Prasanthi, “3D-QSAR Studies of NAIMS Analogs as anti-HIV agents”, Journal of Young Pharmacists, 2009, 1(3), 251-258.

 

14)

Swastika Ganguly and S.P. Bhatnagar, “Development of a Computerized Database for Identification of Indigenous Drugs”, Pharmacognosy Magazine, 2008, 4(14), 65-71.

 

15)

S. Ganguly and S. Banerjee, “3D-QSAR Studies of Imidazole Derivatives as   Candida Albicans P450 – Demethylase Inhibitors” Asian Journal of       Chemistry, 2008, 20(6), 4595-4608.

 

16)

M.Ganesh, K. Kamalakrishnan, Rahul Patil, Satish Upadhyay, Anand Srivastava, T.Sivakumar and Swastika Ganguly, “A validated UV Spectrophotometric method for the determination of letrozole in bulk and solid dosage form”, Rasayan Journal of Chemistry, 2008, 1(1),55-58.

 

17)

M. Ganesh, B. Thangabalan, Dinesh Thakur, K. Srinivasan, Swastika Ganguly and T. Sivakumar, “UV Spectrophotometric Determination of Oxaprozin in   Pure and Pharmaceutical Formulation”, Asian Journal of Chemistry, 2008, 20(7),  5451-54.

 

18)

S. Ganguly and S, Murugesan, “Docking studies of novel tetrahydroquinoline and tetrahydroisoquinoline analogues into the non-nucleoside inhibitor binding site of HIV-1 RT”,  Rasayan Journal of Chemistry, 2008, 1(2), 251-257.

 

19)

Avinash Patil, Swastika Ganguly and Sanjay Surana, “A Systematic Review of Benzimidazole Derivatives as an antiulcer agent”, Rasayan Journal of Chemistry, 2008, 1(3), 447-460.

 

20)

Swastika Ganguly, P. Partani and S. Samanta, “Solid Phase Organic Synthesis (SPOS) - An Overview”. Pharmbit, Jan-Jun 2008, Vol XVIII(1), 12-16.

 

21)

Swastika Ganguly, Amresh Kumar and Ramesh Chandra, “Synthesis and antifungal evaluation of 1-substituted azoles”, Pharmbit, July-Dec.2008, XVIII(2), 105-107.

 

22)

M. Ganesh, P. Sunitha, A. Saravanakumar, K. Srinivasan, M. Vinoba, S. Ganguly and T. Sivakumar, “ A validated RP=HPLC method for simultaneous estimation of acetaminophen and methacarbamol in tablets”, Asian Journal of Chemistry, 2008, 20(8), 6501-6504.

 

23)

Sumit Mishra, Gurdeep Singh, Usha Jha and Swastika Ganguly, “Long term leaching studies on Coal combustion residues from Balco Captive Power Plant, Korba” Journal of Indian Chemical society, April 2008, 85,pp. 429- 433.

 

 

24)

S.Ganguly and S. Banerjee, “Synthesis, Antifungal activity and Molecular Modeling Studies of Some Novel 1-Substituted 2-methylimidazole Analogs”, Journal of Indian Council of Chemists, 2007, 24(1), 178-181.

25)

S. Ganguly and K. Somakala, “Synthesis and Screening of N-(Aryl)-2-(2-Methyl-4-Nitro-1H-Imidazol-1-yl-) Acetamides for Antibacterial Activity” Journal of Institution of Chemists (India), 2007, 79(6), 33-38.

 

26)

S. Ganguly and S, Murugesan, “Molecular Dynamics – A versatile tool for Drug Design”, Pharmbit, Jan-Jun 2007, XV(1), 43-47.

 

Presentations:

1)

Jacob K, S.; Ganguly, S. Molecular Docking Studies of Novel Pyrazole Analogs as Possible HIV-1-RT Inhibitors. In Proceedings of the 18th Int. Electron. Conf. Synth. Org. Chem., 1 - 30 November 2014; Sciforum Electronic Conference Series, Vol. 18, 2014 , b033; doi:10.3390/ecsoc-18-b033

 

2)

Swastika Ganguly, Sony Jacob and S. Murugesan, Molecular Modelling studies, synthesis and evaluation of some (N,N-bis 3,5 dimethyl pyrazole-1-yl)methyl] aniline analogs as possible HIV-1 RT inhibitors, Proceedings of DST sponsored iInternational seminar on Recent Advances in Clinical Research with a special emphasis on BA/Be study organized by Bioequivalence Study Centre , Department of Pharmaceutical Technology, Jadavpur University, Kolkata-India held on 11th -15th September 2014.

 

3)

Jinu Issac, Swastika Ganguly, Santanu Kaity and Animesh Ghosh, Enhancement of bioavailability of telmisartan by comilling with poly(vinyl alcohol), Proceedings of DST sponsored International seminar on Recent Advances in Clinical Research with a special emphasis on BA/Be study organized by Bioequivalence Study Centre , Department of Pharmaceutical Technology, Jadavpur University, Kolkata-India held on 11th -15th September 2014.

 

4)

Biplab Debnath , Swastika Ganguly,In silico design of isatin analogs as possible anti HIV agents with broad spectrum chemotherpeutic properties, Proceedings of International Conference on Drugs for the Future: Infectious Diseases(DFID-2014) at NIPER, Hyderabad on 27th-28th March 2014,p 64.

 

5)

Swastika Ganguly, Surabhi Mishra and Biplab Debnath, Molecular modelling studies of novel 1, 2-diarylimidazoles as possible nnrtis with broad spectrum properties, Proceedings of National Seminar on Challenges, Opportunities and futuristic trend in Pharmacy Education at IIT, BHU on 3rd-4th March,2014, PC-P1.

 

6)

Sankrityayan Ira, Gupta Ankita, Swastika Ganguly, In silico design of 1,2-diarylimidazoles as possible antiHIV agents with broad spectrum chemotherapeutic properties, Proceedings of 2nd Pharm. Tech. IAPST International Conference on New Insights into Diseases and Recent Therapeutic Approaches , Jadavpur University, Kolkata-32, 2014, p-69.

 

7)

Ashok P, Subhash Chander, S. Ganguly,Rafael-Balana Fouce and S. Murugesan,Synthesis and evaluation of beta carboline derivatives as antilesihmanial agents,Proceedings of 2nd UK –India MedChem Congress,organized by IICT, Hyderabad, 22-23 March 2013

8)

Ashok P, Murugesan S and S. Ganguly, Design and comparative docking studies of novel 1-phenyl-2,3,4,9 tetrahydro-1H-pyrido{3,4-b]indole-3-carboxylic analogs as inhibitors of HIV-1-Reverse transcriptase, Proceedings of World Conference on HIV and AIDS 2012, pg 51.

 

9)

Jinu Issac, Santanu Kaity, Swastika Ganguly and Animesh Ghosh,  Bioavailabilty enhancement of Glipizide by microwave induced solid dispersion”, Proceedings for DST sponsored International Seminar on Clinical Research  and Regulatory Affairs-Present scenario on 16th July 2012 held at Dr. K.P. Basu Memorial hall, Jadavpur University organized by Bioequivalence Centre, Dept. of Pharmaceutical; Technology, Jadavpur University, Kolkata-32

10)

Ashok P, Kakumanu Kishore Babu,S. Murugesan and S. Ganguly, “ Design and docking studies of some novel 2-substituted Tetrahydro- β carbolines as Human Immunodeficiency Virus Type-1 Reverse Transcriptase Inhibitors” Proceedings for the 10th Annual Symposium of International Consortium on Antivirals(ICAV) , 2012, pg 56.

 

11)

Baskar L, Papiya Mitramazumder, Dinakar Sasmal, Venkatesan Jayaprakash, Swastika Ganguly and Ashok K. Pattnaik, “Docking studies of some N-1 substituted imidazoles on M1, M2 and M3 receptors: An antidiarrheal efficacy”Proceedings of 63rd  Indian Pharmaceutical Congress, 2011, B30.

 

12)

Swastika Ganguly and Debarun Chatterjee," Docking studies of 1,2 disubstituted imidazoles as possible antiHIV, antimycobacterial and antifungal agents," Proceedings of 63rd Indian Pharmaceutical Congress, 2011, B32.

 

13)

Swastika Ganguly and Arpita Upadhyay," In silico design of 1,4-diarylimidazole -2-thione analogues for possible anticancer activity acting on EGFR receptor", Proceedings of 63rd India Pharmaceutical Congress, 2011, B35.

 

14)

Patel Hardik S. and Swastika Ganguly, “Molecular modeling studies of 3-(4-chlorophenyl)-4-(1H imidazole-1-yl)-5-phenyl-4,5-dihydrp-1H pyrazole derivatives as possible HIV-1-RT inhibitors” Proceedings of 63rd  Indian Pharmaceutical Congress, 2011, B36.

 

15)

Kakumanu Kishore babu, S. Murugesan and S. Ganguly, “ Design and Docking studies of some novel H1N1 neuraminidase inhibitors”, Proceedings of National Conference on Chemical Sciences in New Millennium , Pacific University, Udaipur, Rajasthan, 8th January 2012.

 

16)

Swastika Ganguly and Shweta Sinha," Modelling studies of novel bisimidazoles as possible antiHIV and anti-mycobacterial agents", Proceedings of 3rd Indian Pharmaceutical Association Convention, 2011, 62.

 

17)

Swastika Ganguly and B.S. Nagaraj, “In-silico design of 1,2-disubstituted imidazoles as possible antiHIV with broad spectrum chemotherapeutic agents” Proceedings of 62nd Indian Pharmaceutical Congress, 2010, B272.

18)

R.Kuhu, T. Balaraju, A. Kesharwani, S. Ganguly and A. Sharon, “Targeting Drug Discovery by catalyzing 3D HIV Integrase modelProceedings of BIT’s 1st World Congress of Virus and Infections -2010 (WCVI-2010), page 462.

 

19)

L.Baskar, P. Mitramazumder,D. Sasmal and Swastika Ganguly, “ An in vitro evaluation of the antimicrobial efficacy of some N-substituted imidazoles”Proceedings of Pharmacon 2010, Department of Pharmaceutical Sciences,      April9-10, 2010, pg 34.

 

20)

  1. S.M. Firdous, Swastika Ganguly, Raju Koneri, Anupam Kanti Bag, “Protective effect of Ipornea staphylina on carbon tetrachloride induced hepatotoxicity and Gentamicin induced nephrotoxicity in rats”, Proceedings of Pharmacon 2010, Department of Pharmaceutical Sciences, Birla Institute of Technology, Mesra, Ranchi ,April 9-10, 2010, pg 17.

 

21)

I.Poonilavarasan, Swastika Ganguly, S.R. Trinath and A. Rajasekaran, “Synthesis and anticonvulsant activity of Quinazoline drivatives”, Proceedings of TexoPharma Virtus 09, 2009.

 

22)

               L. Baskar, Papiya Mitra Mazumder, D. Sasmal and S.Ganguly, “Antidiarrheal and

               spasmolytic activities of some N-substituted 2-methylimidazoles”, Proceedings of

               TexoPharma Virtus 09,organized by college of Pharmacy, Mother Theresa PG and

               Research Institute of Health Sciences, Pondicherry, 2009.

 

23)

L. Baskar, Papiya Mitra Mazumder, D. Sasmal and S.Ganguly, “H2 receptor antagonism and antiulcer activity of some N-substituted 2-methylimidazoles”, Proceedings of 61st Indian Pharmaceutical Congress, 2009, 226.

 

24)

Suresh Kumar K, Ganguly S, Clerq ED, Rajasekaran A, “Synthesis, antiviral and cytotoxic evaluation of non nucleoside-3-(benzylideneamino)-2-phenylquinazoline-4(3H)ones”, Proceedings of 61st Indian Pharmaceutical Congress, 2009, 226.

 

25)

Vatsal V. Vithlani, S. Ganguly, N. Panigrahi and P. Mitramazumder, “Design, Synthesis and evaluation of some novel 1-[2-hydroxyethyl]-2-methyl-5-nitroimidazoles as antiHIV agents”, Proceedings of 61st Indian Pharmaceutical Congress, 2009, 274.

 

26)

Poonilavarasan Ilangovan, Swastika Ganguly and Vijay Pandi, “Synthesis  and Pharmacological activities of  Quinazolinone derivatives”, Proceedings of 61st  Indian Pharmaceutical Congress, 2009, 287.

 

27)

Pankaj K. Gupta, Swastika Ganguly and N. Panigrahi, “Binding Mode Analysis of Some Novel 1-(2-Diarylmethoxy)ethyl)-2-methyl-5-nitroimidazole analogs”, Proceedings of the 14th Annual national Convention of Association of Pharmaceutical Teachers of India,organized by Lachoo Memorial College of Sciences and Technology, Pharmacy Wing, 2009, SA55.

 

28)

A. Rajasekaran, I.Poonilavarasan, D. Kalaiyarasi and Swastika Ganguly, “Synthesis, Characterization and Antimicrobial Evaluation of Quinazoline Schiff Bases”, Proceedings of National Level Seminar on Stereochemical Adventures in the synthesis of challenging drug molecules at , 2009, 21-22.

 

29)

Papiya Mitra Mazumder, Swastika Ganguly, D. Sasmal and L. Baskar, “LD 50 Determination and Behavorial Studies of certain novel 1-substituted-2-methylimidazole derivatives: A blind screening ”, Proceedings of 60th Indian Pharmaceutical Congress, 2008, 372.

 

30)

Amresh Kumar and Swastika Ganguly, “Synthesis and evaluation of some azole analogs as potential antifungal agents”, Proceedings of 60th Indian Pharmaceutical Congress, 2008, 245.

 

31)

A.V. Patil, S. Ganguly and S.J. Surana, “Synthesis, Docking and in vivo antiulcer activity of novel 2-(1H-Benzo(D)imidazol-2-yl-sulfinyl)methyl 3-substituted quinazoline-4- (3H)-one derivatives”, Proceedings of 60th Indian Pharmaceutical Congress, 2008, 208.

 

32)

Murugesan S. and Swastika Ganguly, “Docking Studies of Some Novel 1, 2, 3, 4- Tetrahydroisoquinoline analogs as HIV -1- non nucleosidal Reverse Transcriptase Inhibitors”, Proceedings of 60th Indian Pharmaceutical Congress, 2008, 197.

 

33)

R. Kuhu, S. Ganguly and S. Murugesan, “Pharmacophoric Distance Mapping Study of Some Non Nucleosidal Reverse Transcriptase Inhibitors” , Proceedings of 60th Indian Pharmaceutical Congress, 2008, 195.

 

34)

L. Baskar, Papiya Mitramazumder, D. Sasmal and Swastika Ganguly,” Behavorial studies of certain novel 1-substituted 2-methylimidazole derivatives: A blind screening” held in the APTI 13th Annual National Convention at SLT Institute of Pharmaceutical Sciences,Guru Ghasidas University, Bilaspur, from 3rd-4th October,2008.

 

35)

Avinash Patil , Swastika Ganguly , Sanjay Surana , Sanjay Pekamwar, Abhay Sangamwar, Gastric H+ / K+ Atpase as drug target” presented in the International Conference on Drug Discovery and Nanotechnology held in the Department of Chemistry , Yesvant Mahavidyalaya, Nanded , Maharashtra from 27-29 January 2008.

 

36)

V. Gopalakrishnan and Swastika Ganguly, “3DQSAR studies of novel 1-substituted 2-methyl-5-nitroimidazole derivatives as HIV-1 Non Nucleoside Reverse Transcriptase Inhibitors” Proceedings of 26th Annual Conference of Indian Council of Chemists, 2007, 263.

 

37)

S. Murugesan and Swastika Ganguly, “Flexible docking study of some novel quinoline and isoquinoline analogs” Proceedings of 26th Annual Conference of Indian Council of Chemists, 2007 ,262.

 

38)

Baskar, G. Nagalakshmi, Papiya Mitra Mazumder, D Sasmal, Swastika Ganguly, S. Murugesan, “Wound healing and an antimicrobial efficacy of Ixora cocinea Linn root extracts”, L. Proceedings of 59th Indian Pharmaceutical Congress, BHU, Varanasi, 20th – 23rd December, 2007.

 

39)

  Satish Upadhayay, Jagadeswaran M, Rishi Tiwari, Kamalakrishnan, S. Ganguly

      and Sivakumar T, “An u.v. spectrophotometric determination of letrozole in

      bulk and solid dosage form” presented in 59th Indian Pharmaceutical

      Congress, BHU, Varanasi, 20th to 24th December 2007.

 

40)

Rahul Patil, Thangabalan B, Rajavel R, Dinesh Thakur, Ganesh M, S. Ganguly

       and Sivakumar T, “New validated RP-HPLC method for the estimation of

       Oxaprozonin bulk and solid dosage Form” presented in 59th Indian    Pharmaceutical

       Congress, BHU, Varanasi, 20th to 24th December 2007.

41)

 Ganesh M, Rahul Patil, Thangabalan B, Dinesh Thakur, S. Ganguly and

     Sivakumar T, “UV Spectrophotometric determination of Oxaprozin in pure and

     pharmaceutical formulation” presented in 59th Indian Pharmaceutical

 Congress, BHU, Varanasi, 20th to 24th December 2007.

42)

A. Patil, S. Ganguly, S. Suranaand J. Hundiwale, “Synthesis of Benzimidazole

      derivatives as an antiulcer agents” presented in 59th Indian Pharmaceutical

      Congress, BHU, Varanasi, 20th to 24th December 2007.

 

43)

S. Banerjee, S. Ganguly and R. Chandra, “Synthesis, antifungal activity and

      Molecular Modeling studies of some novel 1-substituted 2-methylimidazole

      analogs”, presented in 59th Indian Pharmaceutical Congress, BHU, Varanasi,

      20th to 24th December 2007.

 

44)

L. Baskar, G. Nagalakshmi, Papiya MitraMazumder, D. Sasmal, Swastika Ganguly and S. Murugesan, “ A comparative invitro antimicrobial efficacy of certain 2-substituted oxazole derivatives: Synthesis and depiction” presented in APTI Annual National Convention held at University Institute of Pharmaceutical Sciences, Punjab University, Chandigarh from 25-27 October 2007.

 

45)

Ganesh M, Aruna M, Jagdeswaran M, M. Vinoba, Kamalakannan, Swastika Ganguly and Sivakumar T, “Development and Validation of New RP-HPLC analytical techniques for Letrozole in Bulk and its Solid dosage” presented in the “Trends in Pharmaceutical Sciences -2007” Silver Jubilee Celebration of Department of Pharmacy held in  Annamalai University, Tamil Nadu on 30th-31st October 2007.

46)

 

            Jinu Issac, Swastika Ganguly, Santanu Kaity and Animesh Ghosh, “Enhancement

           of   bioavailability of telmisartan by comilling with poly(vinyl alcohol)”presented

           in the DST  sponsored 5 day International Seminar cum Workshop on RECENT

           ADVANCES IN CLINICAL RESEARCH WITH A SPECIAL EMPHASIS ON

           BA/BE STUDY,heldat Bioequivalence Study centre , Dept of Pharm. Tech.,

           Jadavpur University, Kolkata from 11th to 15th September 2014

 

 

 

 

 

 

 

 

14. Patents filed : Six

                                               

Serial

number

Ref. no.

Application Type

Application Number

Title/Remarks

1

ORDINARY APPLICATION

75/KOL/2012

THIAZOLIDINE-2,4-DIONE DERIVATIVES,THEIR SYNTHESIS AND USES

2.

ORDINARY APPLICATION

655/KOL/2013

NOVEL THIAZOLIDINE-DIONE ANALOGS AS AN ANTIMICROBIAL AGENTS

3.

ORDINARY APPLICATION

1226/KOL/2013

ISATIN(1H-INDOLE-2,3-DIONE)DERIVATIVES,THEIR SYNTHESIS AND USES

4.

ORDINARY APPLICATION

1323/KOL/2013

NOVEL BENZIMIDAZOLES AS ANTIMICROBIALS

5.

ORDINARY APPLICATION

1351/KOL/2014

NOVEL IMIDAZOLES AS ANTIMICROBIALS

6.

ORDINARY APPLICATION

830/KOL/2014

DELIVERY OF TELMISARTAN…..,

PREPARATION THEREOF

 

    15.  Book Chapters: 02

  1. Swastika Ganguly, QSAR in Drug Design, Ed., B. K. Razdan, CBS Publishers, New Delhi, 2012 ,1st Edition,  pg 235-254.
  2. Swastika Ganguly, Molecular Modelling in Drug Design,Ed., B. K. Razdan, CBS Publishers, New Delhi, 2012 , 1st Edition, pg 256-282.

 

16. List of Completed Sponsored Projects as PI. (top 10):

 

Sl. No.

Title

Sponsor

Amount

From Date

To Date

Outcome

 

 

 

 

(Month-Year)

(Month-Year)

 

 

 

 

 

 

 

 

1.

 

In Silico Design, Synthesis and Evaluation of newer azoles as HIV-1-RT inhibitors

 

UGC, New Delhi

 

Rs.13.838 lacs

 

1st April 2013

31st March 2016

3D QSAR model was developed , anumber of newer iazoles analogs were synthesized which showed high IC50 activity against HIV-1RT

2.

Design, Synthesis and evaluation of some DAMNI analogs as Novel   NNRTIs with broad-spectrum chemotherapeutics

AICTE, New Delhi

8.37 lacs

2008

-2010

Some novel DAMNI analogs were designed and developed whch showed interesting activities against HIV -1 RT

3.

Synthesis, Evaluation and Molecular Modeling studies of Some Imidazole analogs as potential Non Nucleoside Reverse Transcriptase Inhibitors

UGC, New Delhi

1.40 lacs

2009

-2011

 

 

 

 

17. Areas of Special Interest:

Since first reported in 1980s, AIDS has spread rapidly through the population and has become a worldwide pandemic. HIV-1 (Human Immunodeficiency Virus Type-1) is the pathogenic retrovirus of the lentivirus family and causative agent of AIDS or AIDS Related Complex (ARC)(11-13). HIV targets the monocytes expressing surface CD4 receptors producing profound defects in cell-mediated immunity. Overtime infection leads to severe depletion of CD4 T-lymphocytes (T-cells) resulting in opportunistic infection (OIs) like tuberculosis (TB), fungal, viral, protozoal and neoplastic diseases and ultimately death.

In general, the inhibitors of HIV-1-RT are classified into two main categories: Nucleoside inhibitors (NRTIs) such as AZT, ddI, ddC and 3TC, and Non Nucleoside inhibitors (NNRTIS), like Nevirapine, delaviridine and efavirenz. Non nucleoside RT inhibitors are an attractive class of anti HIV drugs as they exhibit noncompetitive inhibition and bind at a unique site on the structure of HIV-RT.  The high specificity of NNRTIs over the cellular polymerases results in their diminished toxicity relative to nucleoside analogs. Moroever, the NNRTIs can act synergistically with other classes of antiviral agents such as AZT, interferon or CD4 immunoadhesin. However, the emergence of resistant viral strains severely impairs the long term efficacy of NNRTIs.

To overcome these problems it is necessary that novel NNRTIs are searched with obstinacy either by improvements of existing dug classes or by discovering new agents with maximum therapeutic efficacy and minimum side effects.

 

Level of already achieved success: The Principal Investigator of this proposal has been working on ‘Imidazole analogs’ since 1994. She has several collaborations with different international research laboratories and  groups working in the field of anti HIV agents like  Rega Institute for Medical Research, Belgium ; Institute of Molecular Genetics , National Research Council, Italy ; Division of Infectious Diseases, University of Pittsburgh, School of Medicine, USA; TAACF ,Southern Research Institute ,Birmingham, and with Developmental Therapeutics Program, NCI, NIH, USA. On a national level she has collaboration with Indian Institute of Natural Resins and Gums, Namkom, Ranchi etc. Her experience about different experiments, e.g,. synthesis  of NCEs and molecular modelling etc. will be found useful for the proposed works. The PI has completed three research projects; one AICTE RPS project on ‘DAMNI analogs’; one UGC Minor Research project on “Synthesis, evaluation and molecular modelling of imidazole analogs” and one UGC Major Research Project on “In Silico Design, Synthesis and Evaluation of newer azoles as HIV-1-RT inhibitors. The PI has found very interesting results particularly with imidazoles analogs against HIV-1 RT inhibitors.

 

18.M. Pharm Guidance: >30 students

From 2009-2018

  1. M. Pharm thesis of Naresh Panigrahi entitled” Design, Synthesis and Evaluation of Some Novel 1-[2-Hydroxyethyl]-2-Methyl–5-NitroImidazole Analogs”, May 2009.
  2. M. Pharm thesis of Naru Prasa”,nthi entitled “Design, synthesis & study of some novel N-aminoimidazole analogues”, May 2009.
  3. M. Pharm thesis  of Anup Kr. Kesharwani entitled, “ Rational Design, synthesis and evaluation of some novel nitroimidazole analogs as anti-HIV agents with broad spectrum chemotherapeutic properties”, May 2010.
  4. M. Pharm thesis  of Vatsal Vijay Vithalani entitled “Design, synthesis and evaluation of some novel 1-substituted-2- methyl-4- nitroimidazole analogs”, May 2010.
  5. M. Pharm thesis  of Ritu Kuhu entitled “Molecular modeling, synthesis and evaluation of novel imidazoles as possible HIV-1 integrase inhibitors with broad spectrum activity”, May 2010.
  1. M. Pharm thesis  of Rahul Misra entitled “Design, synthesis and study of some novel 2-methyl imidazole analogs”, May 2010.
    1. M. Pharm thesis of Nagraj B.S. entitled “Design, synthesis and studies of novel imidazoles as possible antimicrobial agents” May 2011.
    2. M. Pharm thesis of Shweta Sinha entitled “Modeling, synthesis and evaluation of novel 2-methylimidazoles as possible antimicrobial agents, May 2011.
    3. M. Pharm thesis of Debarun Chatterjee entitled Design, synthesis and studies of some substituted imidazoles as possible antimicrobial agents, May 2012.
    4. M. Pharm thesis of Arpita Upadyay entitled” Design, synthesis and studies of 1, 4-diaryimidazole -2-thione analogues for possible anticancer activity, May 2012.
    5. M. Pharm thesis of Patel Hardik Sureshchandra entitled “Design, synthesis and studies of diaryl imidazoles as possible broad spectrum chemotherapeutic agents”, May 2012.
    6. M. Pharm thesis of Pankaj Kumar entitled “Estimation and validation of HPLC method for quantitation of Tizanidine in tablet dosage forms”, May 2012.
    7. M. Pharm thesis of Ankita Gupta entitled “Design, synthesis and evaluation of 1,2-disubstituted imidazoles as broad spectrum chemotherapeutic agents”, May 2013.
    8. M. Pharm thesis of Nalini Singh entitled Design, synthesis and studies of 1,4-diaryl imidazole -2-thiones as antimicrobials”, May 2013.
    9.  M. Pharm thesis of Sandip Dolui entitled Synthesis and study of 1,2 diaryl imidazole ethanones as antimicrobial agents”, May 2013.
    10. M. Pharm thesis of Ira Sankrityayan entitled Synthesis , evaluation and binding mode analysis  of 1-substituted 2-methyl4-nitroimidazoles as antimicrobials”, May 2014.
    11. M. Pharm thesis of Surbhi Mishra entitled Design, synthesis  and evaluation of 1,2-disubstituted imidazoles as broad spectrum chemotherapeutic agents”, May 2014.
    12. M. Pharm thesis of Chandrakant entitled “SYNTHESIS AND STUDIES OF 1-SUBSTITUTED IMIDAZOLES AS ANTIMICROBIAL AGENTS, May 2015
    13. M. pharm thesis of Prity Kumari entitled “SYNTHESIS AND STUDY  OF Novel N- SUBSTITUTED IMIDAZOLES May 2018
    14. M. Pharm thesis of Priya Shaw  entitled “SYNTHESIS AND STUDY OF NOVEL N-SUBSTITUTED IMIDAZOLES, 2017

 

 

19. Ph.D. Guidance:

 

Ph.D. thesis awarded: 11

 

  1. Ph.D. thesis of Murugesan S. entitled “Synthesis and study of some novel benzopiperidine analogs”, 2009.
  2. Ph.D. thesis of Avinash Vishwanath Patil. entitled “Synthesis and study of some novel benzimidazole analogs as potential antiulcer agents”, 2011.
  3. Ph.D. thesis of K. Suresh Kumar. entitled “Design, Synthesis and Evaluation of Some Novel Quinazoline Analogs”, 2012.
  4. Ph.D. thesis of Jinu Issac entitled “Enhancement of bioavailability of poorly water soluble drugs by suitable physical methods for the treatment of hypertension and diabetes mellitus ”,2015.
  5. Ph.D. thesis of Subhashish Banerjee entitled “Synthesis and study of some novel triazole derivatives”,2015.
  6. Ph.D. thesis of Radhe Shyam Bahare entitled “Synthesis and study of some novel thiazolidine analogs”,2017.
  7. Ph.D. thesis of Jagdish Sahu entitled “Synthesis and study of some fused triazole analogs”,2017.
  8. Ph.D. thesis of Geeta Yadav entitled “Synthesis and study of some novel benzimidazole analogs”,2017.
  9. Ph.D. thesis of Pravin Kr. Sable entitled “Synthesis and study of some diketo analogues as possible antimicrobial agents”,2017.
  10. Ph.D. thesis of Biplab Debnath entitled “Synthesis and study of some newer isatin analogs”,2018.
  11. Ph.D. thesis of Sony Issac entitled “Synthesis and study of some newer pyrazole analogs”,2019.

 

Ph.D. thesis submitted: 2

  1. Ph.D. thesis of Rohit Singh entitled “Design, synthesis and study of some newer N-substituted azoles”,2018
  2. Ph.D. thesis of Naresh Panigrahi entitled “Synthesis and study of some novel oxazolidinone analogs”, 2019.

 

Any other matter:

  1. Organized a virtual lecture on “Cardiac Pulmonary Resuscitation” by Dr. Vemuri  , Faculty of the Department of Emergency Medicine , University of Ilinois at Chicago on 17th January 2019 from 5:30 to 6:30 pm.

 

 

 

 

 

 

 

 

 

19. Referees (up to 3)

Name

Designation

Organization

Email id

Phone

Dr. Tarun Jha

Professor

Department of Pharmaceutical Technology, Jadavpur, West Bengal

drtarunjha@yahoo.com

09433187443

 

Dr. B. N. Sinha

Professor

Department of Pharmaceutical Sciences and Technology, Birla Institute of Technology, Mesra, Ranchi-835215

bnsinha@bitmesra.ac.in

09431382671

Dr. S. C. Si,

 

Dean and Professor

School of Pharmaceutical Sciences,

Shiksha o anusandhan University,

Kalinga Nagar,

Ghatikia, Bhubaneshwar -751003

 

sudamchandrasi@yahoo.com

 

09437035908

                                                                                                                                               

I do hereby confirm that the above-furnished information is true to the best of my knowledge and belief.

 

S. Ganguly